Segui
Myles Brown
Myles Brown
Emil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School
Email verificata su dfci.harvard.edu - Home page
Titolo
Citata da
Citata da
Anno
Model-based analysis of ChIP-Seq (MACS)
Y Zhang, T Liu, CA Meyer, J Eeckhoute, DS Johnson, BE Bernstein, ...
Genome biology 9 (9), 1-9, 2008
111322008
Cofactor dynamics and sufficiency in estrogen receptor–regulated transcription
Y Shang, X Hu, J DiRenzo, MA Lazar, M Brown
Cell 103 (6), 843-852, 2000
19532000
Genome-wide analysis of estrogen receptor binding sites
JS Carroll, CA Meyer, J Song, W Li, TR Geistlinger, J Eeckhoute, ...
Nature genetics 38 (11), 1289-1297, 2006
15182006
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1
JS Carroll, XS Liu, AS Brodsky, W Li, CA Meyer, AJ Szary, J Eeckhoute, ...
Cell 122 (1), 33-43, 2005
14372005
Molecular determinants for the tissue specificity of SERMs
Y Shang, M Brown
Science 295 (5564), 2465-2468, 2002
13642002
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
W Li, H Xu, T Xiao, L Cong, MI Love, F Zhang, RA Irizarry, JS Liu, ...
Genome biology 15 (12), 1-12, 2014
10642014
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
E Giovannucci, MJ Stampfer, K Krithivas, M Brown, A Brufsky, J Talcott, ...
Proceedings of the National Academy of Sciences 94 (7), 3320-3323, 1997
10381997
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription
M Lupien, J Eeckhoute, CA Meyer, Q Wang, Y Zhang, W Li, JS Carroll, ...
Cell 132 (6), 958-970, 2008
9822008
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
9572009
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ...
Nature medicine 24 (10), 1550-1558, 2018
9522018
Differential Activation of Peroxisome Proliferator-activated Receptors by Eicosanoids (∗)
K Yu, W Bayona, CB Kallen, HP Harding, CP Ravera, G McMahon, ...
Journal of Biological Chemistry 270 (41), 23975-23983, 1995
8811995
X chromosomal abnormalities in basal-like human breast cancer
AL Richardson, ZC Wang, A De Nicolo, X Lu, M Brown, A Miron, X Liao, ...
Cancer cell 9 (2), 121-132, 2006
8772006
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription
S Halachmi, E Marden, G Martin, H MacKay, C Abbondanza, M Brown
Science 264 (5164), 1455-1458, 1994
8251994
Formation of the androgen receptor transcription complex
Y Shang, M Myers, M Brown
Molecular cell 9 (3), 601-610, 2002
8002002
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ...
Science 338 (6113), 1465-1469, 2012
7542012
A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth
Q Wang, W Li, XS Liu, JS Carroll, OA Jnne, EK Keeton, AM Chinnaiyan, ...
Molecular cell 27 (3), 380-392, 2007
6812007
Polarity-specific activities of retinoic acid receptors determined by a co-repressor
R Kurokawa, M Sderstrm, A Hrlein, S Halachmi, M Brown, ...
Nature 377 (6548), 451-454, 1995
6801995
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
X Chen, D Iliopoulos, Q Zhang, Q Tang, MB Greenblatt, M Hatziapostolou, ...
Nature 508 (7494), 103-107, 2014
6742014
Cistrome: an integrative platform for transcriptional regulation studies
T Liu, JA Ortiz, L Taing, CA Meyer, B Lee, Y Zhang, H Shin, SS Wong, ...
Genome biology 12 (8), 1-10, 2011
6282011
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
SY Ku, S Rosario, Y Wang, P Mu, M Seshadri, ZW Goodrich, ...
Science 355 (6320), 78-83, 2017
5912017
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20